”Positive results from PK study with cobitolimod” selected as one of the best abstracts for poster presentation at UEGW
August 22, 2023 – InDex Pharmaceuticals Holding AB (publ) today announced that the positive results from the pharmacokinetic (PK) study with cobitolimod in patients with moderate to severe ulcerative colitis will be presented at one of the leading gastroenterology conferences, the United European Gastroenterology Week (UEGW). The abstract was selected as one of the best abstracts for poster presentation and is therefore also chosen to be presented orally in one of the moderated poster sessions.“We are very pleased that our presentation of the PK study results was selected as one of the best